DOI: 10.21276/ajptr
Tue, 21 May 2019

Evaluation of Antihyperglycemic and Lipid Lowering Activity of Caralluma Fimbriata in Diabetes Induced rats.

Sandeep Jagtap1*, P.P. Shidore2, S.V. Dange2

1. Serum Institute of India Ltd, Pune, India

2. Department of Pharmacology, Dr. D Y Patil Medical College, Pimpri, Pune, India.


This study evaluates antihyperglycemic and lipid lowering activity of Caralluma fimbriata in dexamethasone induced diabetic rats. Serum glucose and lipid lowering activity of Caralluma fimbriata was tested at dose of 50 mg/kg and 100 mg/kg per oral route against dexamethasone induced hyperlipidemia and hyperglycemia in Spraugue-Dawley (SD) rats. On day 11, blood was collected for the estimation of serum glucose and lipids. Caralluma fimbrita in both the doses significantly decreased Serum glucose, total cholesterol, triglyceride and LDL as compared to dexamethasone only group (P <0.05). Caralluma fimbriata has a significant antihyperglycaemic and lipid lowering activity in experimental rat models of diabetes.

Keywords: Caralluma fimbriata, glucose, lipid, dexamethasone, diabetes

[PDF]   Viewed: 1652   Downloaded: 137
  • Call for paper

    American Journal of PharmTech Research (AJPTR) is a peer-reviewed, bimonthly official international journal allowing access to abstracts and full-text.



  • Email & SMS Alerts

    Email/SMS alert system is one of the key features and gives update information about the submitted manuscript.


  • Article Statastics

    American Journal of PharmTech Research (AJPTR) provides unique facility for authors to know popularity of articles on basis of numbers of PDF download and views. It will display in tabulated format.

  • Online Submission

    American Journal of PharmTech Research (AJPTR) is one of the International open access journal devoted to various disciplines in science and technology.


web counter
web counter